Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels.

The cardiovascular protective effects of estrogen are known to be mediated by its beneficial effects on lipid metabolism and its direct actions on the vessel wall. The latter can be mediated by a specific receptor for estrogen present on smooth muscle cells and endothelial cells. The gene for the receptor (the classic estrogen receptor [ER]) has three known polymorphisms, Pvu II, Xba I, and B-variant polymorphisms, which are reportedly associated with receptor expression and altered receptor function and with some disorders including breast cancer, hypertension, and spontaneous abortion. However, the significance of genetic variations of the ER in vascular diseases has not been reported. We have examined the association between coronary artery disease (CAD) and the three polymorphisms in ER. Genotypes (P1/P2, X1/X2, and B-wild type/B-variant type) were determined in 87 men and postmenopausal women with myocardial infarction or angina pectoris whose lesions were confirmed by coronary angiography, as well as from 94 control individuals from the general population with no coronary heart disease and normal resting ECG. For B-variant polymorphism, all individuals examined had B-wild type, which contrasts with the reported allele frequency for B-variant type (0.1) in the white population. Genotype distributions and allele frequencies of Pvu II or Xba I polymorphisms were not significantly different between control subjects and patients (P > .05 for Pvu II or Xba I genotypes; P > .05 for Pvu II or Xba I allele frequencies). When the allele frequencies were analyzed separately by sex, there was still no statistically significant difference for both polymorphisms (P > .05 for men; P > .05 for women). No association was found between the polymorphisms and the angiographic severity of CAD. Total cholesterol, triglyceride, or HDL-cholesterol levels were not significantly different among ER genotypes. These findings suggest that the three polymorphisms in ER are not associated with the prevalence and severity of CAD and that the polymorphisms are unrelated to the serum lipid levels in control subjects and patients.

[1]  M. Thorogood.  Oral contraceptives and myocardial infarction: new evidence leaves unanswered questions. , 1997, Thrombosis and haemostasis.

[2]  R. Karas,et al.  Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice , 1997, Nature Medicine.

[3]  I. Han,et al.  Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. , 1997, The Journal of clinical endocrinology and metabolism.

[4]  J. Rossouw.  Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon. , 1996, Circulation.

[5]  V. Seagroatt.  An introduction to medical statistics (2nd ed.) , 1996 .

[6]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[7]  D. Vaughan,et al.  Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. , 1996, Circulation.

[8]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[9]  R. Kloner,et al.  β-Estradiol, but not α-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion , 1996 .

[10]  R. Clarke,et al.  Specific binding of estradiol to rat coronary artery smooth muscle cells , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  P. Ramwell,et al.  The vascular protective effects of estrogen , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  V. Hombach,et al.  Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. , 1996, Atherosclerosis.

[13]  Y. Ouchi,et al.  Association of bone mineral density with polymorphism of the estrogen receptor gene , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  K. Heimdal,et al.  Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  S. Lehrer,et al.  An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion. , 1994, American journal of obstetrics and gynecology.

[16]  Y. Ouchi,et al.  Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells. , 1994, Endocrinology.

[17]  I. Charles,et al.  Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Karas,et al.  Human vascular smooth muscle cells contain functional estrogen receptor. , 1994, Circulation.

[19]  J. Isner,et al.  Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. , 1994, Circulation.

[20]  Y. Ouchi,et al.  Vascular smooth muscle cells as target for estrogen. , 1993, Biochemical and biophysical research communications.

[21]  P. Poole‐Wilson,et al.  Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease , 1993, The Lancet.

[22]  B. Wróblewska,et al.  Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery , 1993, British journal of pharmacology.

[23]  S. Lehrer,et al.  Estrogen receptor variant and hypertension in women. , 1993, Hypertension.

[24]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[25]  D. Herrington,et al.  Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. , 1992, Journal of the American College of Cardiology.

[26]  A. Wilcox,et al.  B region variant of the estrogen receptor gene. , 1992, Nucleic acids research.

[27]  W D Dupont,et al.  Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. , 1992, Cancer research.

[28]  S. Manuck,et al.  Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. , 1990, Arteriosclerosis.

[29]  P. Sarrel.  Ovarian hormones and the circulation. , 1990, Maturitas.

[30]  C. Langman,et al.  Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  S. Thung,et al.  Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer , 1990, The Lancet.

[32]  W. McGuire,et al.  Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. , 1989, Cancer research.

[33]  S. Lehrer,et al.  A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. , 1988, Molecular endocrinology.

[34]  R. Knopp,et al.  Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. , 1988, American journal of obstetrics and gynecology.

[35]  L. del Senno,et al.  PvuII RFLP inside the human estrogen receptor gene. , 1987, Nucleic acids research.

[36]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[37]  M. Brown,et al.  Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Buetow,et al.  Nonuniform recombination within the human beta-globin gene cluster. , 1984, American journal of human genetics.

[39]  G. Gensini,et al.  A more meaningful scoring system for determining the severity of coronary heart disease. , 1983, The American journal of cardiology.

[40]  S. Shapiro,et al.  Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. , 1981, The New England journal of medicine.

[41]  N. Blin,et al.  A general method for isolation of high molecular weight DNA from eukaryotes. , 1976, Nucleic acids research.

[42]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .